Cancer
Owlstone Medical Recruits First Patient in Phase 2 Clinical Trial for the Early Detection of Lung Cancer through Breath Biopsy®
10 Oct 2023
Read More
Science & Research
Owlstone Medical Publishes Exciting Liver Data on the use of an EVOC® Probe for the Early Detection of Cirrhosis
Read More
9 Nov 2023
Cardiovascular & metabolic disease
Owlstone Medical Presents Data Demonstrating Progress in Development of Breath Biopsy® Tests for Liver Cirrhosis and NASH
Read More
22 Jun 2023
Cancer
Owlstone Medical Presents Data Demonstrating Progress in Development of Breath Biopsy® Test for the Early Detection of Lung Cancer
Read More
14 Jun 2023
Gut & Digestion
Owlstone Medical Launches OMED Health to Enable Patients to Better Understand their Gut Microbiome and Manage their Digestive Health
Read More
4 Apr 2023
FAIMS
Owlstone Medical Wins Contract from U.S. Department of Defense to Develop Handheld Breath Biopsy Device for Early Infectious Disease Detection
Read More
17 Mar 2023
Cancer
Owlstone Medical Enters Partnership with Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection
Read More
15 Mar 2023
Breath Biopsy
Owlstone Medical Publishes Data on the Use of Exhaled Volatile Organic Compounds as Biomarkers for Liver Disease Detection
Read More
6 Feb 2023
Company Updates
Owlstone Medical Launches Breath Biopsy VOC Atlas
Read More
7 Dec 2022
Breath Biopsy
Aviva Invests in Owlstone Medical Breath Biopsy® platform
Read More
1 Sep 2022
Media Mentions
Nature Biotechnology – Diagnostics to take your breath away
Read More
30 Jun 2022
Company Updates
Owlstone Medical Appoints Mark Capone to Board of Directors
Read More
16 Sep 2021
Breath Biopsy
Owlstone Medical Closes $58 Million USD (c. £42 Million GBP) Oversubscribed Financing Round to Continue to Advance Breath Biopsy
Read More
7 Sep 2021
1 2 3 4 5 8

Talk to us about your biomarker research and how Breath Biopsy could help.